Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR-T Cell-Derived Exosomes and Cancer Immunotherapy: Advancing Production and Delivery Through Biofabrication.

Biofabrication·2026
Same author

Targeting CB1 and TRPM8 receptors to counteract CD8+ T cell exhaustion.

Scientific reports·2026
Same author

Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine.

Advanced drug delivery reviews·2026
Same author

Dendritic cells targeted CEA tumor antigen through DEC205 in combination with oncolytic reovirus stimulate strong immune response in colorectal cancer model.

Cellular immunology·2026
Same author

Low rate of red cell alloimmunization among multiply transfused beta-thalassemia major patients in the Wasit province of Iraq.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025
Same author

Efficient gene delivery to immune cells via a recombinant multifunctional chimeric peptide nanocarrier: Implications in immunotherapy.

Nanomedicine : nanotechnology, biology, and medicine·2025

Related Experiment Video

Updated: Jun 8, 2026

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

Tolerance Induction by CD40 Blocking through Specific Antibody in Dendritic Cells.

Mohammad Hossein Karimi1, Padideh Ebadi, Ali Akbar Pourfathollah

  • 1Immunology Department, Tarbiat Modares University, Tehran, Iran. pourfa@modares.ac.ir.

Iranian Journal of Allergy, Asthma, and Immunology
|October 19, 2010
PubMed
Summary

Blocking antibodies targeting CD40 on dendritic cells (DCs) can inhibit T cell activation. This study shows CD40 blockade promotes Th2 cytokine production and reduces IL-12 secretion, highlighting its role in tolerogenic DCs.

More Related Videos

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Related Experiment Videos

Last Updated: Jun 8, 2026

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Co-stimulatory molecule interactions are crucial for T cell activation.
  • Blocking antibodies can inhibit specific receptor-ligand interactions.
  • The CD40 pathway plays a role in T cell stimulation.

Purpose of the Study:

  • To investigate the effect of a blocking antibody against CD40 on dendritic cell (DC) T cell stimulatory potential.
  • To determine how CD40 blockade influences cytokine secretion and allostimulatory function.

Main Methods:

  • Dendritic cells (DCs) were isolated from mouse spleens and cultured in vitro.
  • A blocking antibody against CD40 (Clone HM40-3) was used, with its titer determined by flow cytometry.
  • DCs were treated with the antibody and assessed in a mixed lymphocyte reaction (MLR) assay.

Main Results:

  • CD40 blockade increased IL-4 secretion, promoting Th2 cytokine production by allogeneic T cells.
  • IL-12 secretion by DCs decreased following CD40 blockade.
  • DCs with reduced CD40 expression showed diminished responses to alloantigen stimulation in MLR.

Conclusions:

  • The CD40 pathway is important for the generation of tolerogenic DCs.
  • Downregulation of CD40 effectively inhibits the allostimulatory function of DCs.
  • Targeting CD40 offers a strategy for modulating immune responses.